Cargando…

The predictive value of (18)F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy

BACKGROUND: Patients with locally advanced non-small-cell lung cancer (LA-NSCLC) have poor prognosis despite several multimodal approaches. Recently, low-dose fractionated radiotherapy concurrent to the induction chemotherapy (IC-LDRT) has been proposed to further improve the effects of chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattoli, Maria Vittoria, Massaccesi, Mariangela, Castelluccia, Alessandra, Scolozzi, Valentina, Mantini, Giovanna, Calcagni, Maria Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217210/ https://www.ncbi.nlm.nih.gov/pubmed/28057034 http://dx.doi.org/10.1186/s13014-016-0737-0

Ejemplares similares

The kinetics of (18)F-FDG in lung cancer: compartmental models and voxel analysis
por: Silvestri, Erica, et al.
Publicado: (2018)

(18) F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose
por: Massaccesi, Mariangela, et al.
Publicado: (2012)

The Prognostic Value of (18)F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review
por: Taralli, Silvia, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study
por: Caldarella, Carmelo, et al.
Publicado: (2021)

Dynamic (11)C-Methionine PET-CT: Prognostic Factors for Disease Progression and Survival in Patients with Suspected Glioma Recurrence
por: Mattoli, Maria Vittoria, et al.
Publicado: (2021)

Application of Artificial Neural Network to Preoperative (18)F-FDG PET/CT for Predicting Pathological Nodal Involvement in Non-small-cell Lung Cancer Patients
por: Taralli, Silvia, et al.
Publicado: (2021)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

The Additional Value of (18)F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
por: Quartuccio, Natale, et al.
Publicado: (2020)

Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)

The Predictive Value of Pretreatment (18)-F-FDG-PET-CT in Locally Advanced Nasopharyngeal Cancer Patients Treated Definitively with Induction Chemotherapy Followed by Concurrent Chemo-Radiotherapy
por: Zaghloul, Hala A, et al.
Publicado: (2014)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and (18)F-FDG PET/CT for radiotherapy target volume definition
por: Guberina, Maja, et al.
Publicado: (2021)

(18)F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data
por: Besson, Florent L., et al.
Publicado: (2020)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring (18)F-FDG-PET/CT
por: Meijer, Tineke W.H., et al.
Publicado: (2018)

Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling
por: Boscolo Galazzo, Ilaria, et al.
Publicado: (2016)

Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous
por: Mattoli, Maria Vittoria, et al.
Publicado: (2020)

Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
por: Al-Ibraheem, Akram, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Advanced NSCLC: [(18)F]FDG PET/CT as a Troubleshooter in Treatment Response
por: Ferrari, Cristina, et al.
Publicado: (2021)

Differences between TNM classification and 2-[(18)F]FDG PET parameters of primary tumor in NSCLC patients
por: Cegla, Paulina, et al.
Publicado: (2021)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Short 2-[(18)F]Fluoro-2-Deoxy-D-Glucose PET Dynamic Acquisition Protocol to Evaluate the Influx Rate Constant by Regional Patlak Graphical Analysis in Patients With Non-Small-Cell Lung Cancer
por: Indovina, Luca, et al.
Publicado: (2021)

Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC
por: Tamura, Tomohiro, et al.
Publicado: (2014)

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC
por: Rossi, David, et al.
Publicado: (2012)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study
por: Allocca, Michela, et al.
Publicado: (2021)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT
por: Park, Sohyun, et al.
Publicado: (2020)

Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of (18)F-FDG PET/CT
por: Li, Shaolei, et al.
Publicado: (2013)

Repeatability of [(18)F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
por: Kolinger, Guilherme D., et al.
Publicado: (2019)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vngpls5i5bmdvlh16kg3n4j1qp